1st Edition
Pharmacotherapy of Cachexia
606 Pages
72 B/W Illustrations
by
CRC Press
608 Pages
by
CRC Press
Also available as eBook on:
Although a wealth of information can be found scattered throughout periodicals and research papers, tracking down the most effective treatment for a heterogeneous syndrome such as cachexia can be problematic. Edited by experts in the field, with contributions from a multidisciplinary panel, Pharmacotherapy of Cachexia is the first book devoted solely to the treatment of cachexia with a focus on... Read more
PATHOPHYSIOLOGY OF CACHEXIA
Malnutrition and Cachexia, C.G. Goncalves, A.L.C. Campos, J.C.U. Coelho, S. Suzuki, and M.M. Meguid
Anorexia: Central and Peripheral Mechanisms, S. Perboni, G. Mantovani, A. Inui, and Y. Takimoto
Skeletal Muscle Atrophy and Hypertrophy, D.J. Glass
Skeletal Muscle Apoptosis in Cachexia and Aging, A.J. Dirks and C. Leeuwenburgh
Neurohormonal Factors, A.L. Clark
Cytokines and the Pathophysiology of Skeletal Muscle Atrophy, V.E. Baracos
DISEASES ASSOCIATED WITH CACHEXIA
Diseases Associated with Cachexia: Cancer, R.J.E. Skipworth, M. Dahele, and K.C.H. Fearon
Cachexia Associated with AIDS, K. Berneis and K. Utech
Rheumatoid Cachexia, L.A. Coleman
Chronic Kidney Disease, B. Lindholm, J. Axelsson, O. Heimbürger, A.R. Qureshi, T. Cederholm, and P. Stenvinkel
Cardiac Failure, P.A. Poole-Wilson
Chronic Obstructive Pulmonary Disease, A.M.W.J. Schols
Cachexia in Older Persons, J.E. Morley
GENERAL THERAPEUTIC ASPECTS
Treatment Goals, A.J.S. Coats
Nutritional Treatment of Cachexia, C. Falconnier and U. Keller
DRUGS IN CLINICAL USE
Appetite Stimulants, M. John
Cardiac Cachexia - Drugs in Clinical Use, S. Strassburg and S.D. Anker
ß2-Adrenergic Agonists in the Treatment of Muscle Atrophy, C.P. Lambert, E.Y. Uc, and W.J. Evans
Androgens, Anabolic Steroids, and Glucocorticoids, L. Harle, S. Basaria, and A.S. Dobs
Growth Hormone, P.V. Carroll
Anti-Inflammatory Agents in Cancer Cachexia, M.P. Davis
DRUGS IN RESEARCH AND DEVELOPMENT
The Yin and Yang of IGF-1 and Ghrelin, R.G. Clark
Erythropoietin -A Novel Therapeutic Option for Cachectic Patients, P. Ponikowski, E.A. Jankowska, and W. Banasiak
Statins, S. von Haehling and S.D. Anker
Xanthine Oxidase Inhibitors and Insulin Sensitizers, W. Doehner
Tumor Necrosis Factor Inhibitors in the Management of Cancer-Associated Weight Loss Syndrome, S. Patiyil and A. Jatoi
FUTURE DRUG TARGETS
Central Pharmacological Targets, D.L. Marks
The Ubiquitin-Proteasome Pathway, M. Brink
Peripheral Signaling Pathways Involved in Muscle Loss, S. Possekel, T. Meier, and M.A. Ruegg
Perspectives and Outlook, K.G. Hofbauer, S.D. Anker, A. Inui, and J.R. Nicholson
Malnutrition and Cachexia, C.G. Goncalves, A.L.C. Campos, J.C.U. Coelho, S. Suzuki, and M.M. Meguid
Anorexia: Central and Peripheral Mechanisms, S. Perboni, G. Mantovani, A. Inui, and Y. Takimoto
Skeletal Muscle Atrophy and Hypertrophy, D.J. Glass
Skeletal Muscle Apoptosis in Cachexia and Aging, A.J. Dirks and C. Leeuwenburgh
Neurohormonal Factors, A.L. Clark
Cytokines and the Pathophysiology of Skeletal Muscle Atrophy, V.E. Baracos
DISEASES ASSOCIATED WITH CACHEXIA
Diseases Associated with Cachexia: Cancer, R.J.E. Skipworth, M. Dahele, and K.C.H. Fearon
Cachexia Associated with AIDS, K. Berneis and K. Utech
Rheumatoid Cachexia, L.A. Coleman
Chronic Kidney Disease, B. Lindholm, J. Axelsson, O. Heimbürger, A.R. Qureshi, T. Cederholm, and P. Stenvinkel
Cardiac Failure, P.A. Poole-Wilson
Chronic Obstructive Pulmonary Disease, A.M.W.J. Schols
Cachexia in Older Persons, J.E. Morley
GENERAL THERAPEUTIC ASPECTS
Treatment Goals, A.J.S. Coats
Nutritional Treatment of Cachexia, C. Falconnier and U. Keller
DRUGS IN CLINICAL USE
Appetite Stimulants, M. John
Cardiac Cachexia - Drugs in Clinical Use, S. Strassburg and S.D. Anker
ß2-Adrenergic Agonists in the Treatment of Muscle Atrophy, C.P. Lambert, E.Y. Uc, and W.J. Evans
Androgens, Anabolic Steroids, and Glucocorticoids, L. Harle, S. Basaria, and A.S. Dobs
Growth Hormone, P.V. Carroll
Anti-Inflammatory Agents in Cancer Cachexia, M.P. Davis
DRUGS IN RESEARCH AND DEVELOPMENT
The Yin and Yang of IGF-1 and Ghrelin, R.G. Clark
Erythropoietin -A Novel Therapeutic Option for Cachectic Patients, P. Ponikowski, E.A. Jankowska, and W. Banasiak
Statins, S. von Haehling and S.D. Anker
Xanthine Oxidase Inhibitors and Insulin Sensitizers, W. Doehner
Tumor Necrosis Factor Inhibitors in the Management of Cancer-Associated Weight Loss Syndrome, S. Patiyil and A. Jatoi
FUTURE DRUG TARGETS
Central Pharmacological Targets, D.L. Marks
The Ubiquitin-Proteasome Pathway, M. Brink
Peripheral Signaling Pathways Involved in Muscle Loss, S. Possekel, T. Meier, and M.A. Ruegg
Perspectives and Outlook, K.G. Hofbauer, S.D. Anker, A. Inui, and J.R. Nicholson
Biography
Karl G. Hofbauer, Stefan D. Anker, Akio Inui, Janet R. Nicholson
